J Clin Oncol 41 (22): 3867-3872, 2023.[PUBMED Abstract] Allison KH, Hammond MEH, Dowsett M, et al.: Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.
J Clin Oncol 38 (12): 1346-1366, 2020.[PUBMED Abstract] Buyse M, Loi S, van't Veer L, et al.: Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.
J Natl Cancer Inst 98 (17): 1183-92, 2006.[PUBMED Abstract] Wittner BS, Sgroi DC, Ryan PD, et al.: Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort.
Clin Cancer Res 14 (10): 2988-93, 2008.[PUBMED Abstract] Mook S, Knauer M, Bueno-de-Mesquita JM, et al.: Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature.